Anne Frese
Oficial de Recursos Humanos en MEI PHARMA, INC. .
Perfil
Anne Frese is currently the Chief People Officer at MEI Pharma, Inc. Her former jobs include being the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2015 to 2018, and the Vice President of Human Resources at Artiva Biotherapeutics, Inc. from 2019 to 2021.
She also held the position of Chief Human Resources Officer at Vyripharm Enterprises LLC.
Ms. Frese received her undergraduate degree from McGill University.
Cargos activos de Anne Frese
| Empresas | Cargo | Inicio |
|---|---|---|
| MEI PHARMA, INC. | Oficial de Recursos Humanos | 22/06/2022 |
Antiguos cargos conocidos de Anne Frese.
| Empresas | Cargo | Fin |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Oficial de Recursos Humanos | 01/07/2021 |
| BELLICUM PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/07/2018 |
Vyripharm Enterprises LLC
 Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Oficial de Recursos Humanos | - |
Formación de Anne Frese.
| McGill University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Vyripharm Enterprises LLC
Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Frese